Inventor · disambiguated record
Urban Lundberg
Also filed as: LUNDBERG URBAN
19 granted patents·12 pending applications·92 citations·filing 2007–2024
94Inventor score
Top patents by PatentIndex Score
31 records- 0196US11572392B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2020·Granted Feb 7, 2023·6 cites·23 claims
- 0294US10766931B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2018·Granted Sep 8, 2020·9 cites·19 claims
- 0393US11357846B2Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3VALNEVA SE·Filed 2021·Granted Jun 14, 2022·3 cites·17 claims
- 0493US11208439B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2018·Granted Dec 28, 2021·6 cites·19 claims
- 0593US9975927B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2015·Granted May 22, 2018·13 cites·11 claims
- 0693US9926343B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2016·Granted Mar 27, 2018·10 cites·18 claims
- 0792US12195501B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2021·Granted Jan 14, 2025·1 cites·23 claims
- 0891US12011477B2Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3VALNEVA SE·Filed 2022·Granted Jun 18, 2024·1 cites·22 claims
- 0991US11466058B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2019·Granted Oct 11, 2022·4 cites·10 claims
- 1091US10544194B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2016·Granted Jan 28, 2020·8 cites·9 claims
- 1189US8986704B2Mutant fragments of OspA and methods and uses relating theretoINTERCELL AUSTRIA AG·Filed 2013·Granted Mar 24, 2015·18 cites·12 claims
- 1284US12018054B2Multivalent OspA polypeptides and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2018·Granted Jun 25, 2024·3 cites·20 claims
- 1382US2023295245A1Mutant fragments of ospa and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 1481US2023322869A1Mutant fragments of ospa and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2023·Application pending·0 cites
- 1580US12162909B2Subunit vaccine for treatment or prevention of a respiratory tract infectionVALNEVA SE·Filed 2023·Granted Dec 10, 2024·0 cites·19 claims
- 1679US8129165B2Borrelia antigensLUNDBERG URBAN·Filed 2007·Granted Mar 6, 2012·5 cites·8 claims
- 1778US12331084B2Multivalent OspA polypeptides and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2024·Granted Jun 17, 2025·0 cites·20 claims
- 1878US8303961B2Borrelia antigensLUNDBERG URBAN·Filed 2012·Granted Nov 6, 2012·3 cites·13 claims
- 1978US2025171501A1A subunit vaccine for treatment or prevention of a respiratory tract infectionVALNEVA SE·Filed 2024·Application pending·0 cites
- 2073US8236326B2Klebsiella antigensBAKSHI SHARMILA·Filed 2008·Granted Aug 7, 2012·2 cites·11 claims
- 2166US2024358812A1Human metapneumovirus combination vaccineVALNEVA SE·Filed 2022·Application pending·0 cites
- 2266US2024181034A1Human metapneumo virus vaccineVALNEVA SE·Filed 2022·Application pending·0 cites
- 2365US12162907B2Subunit vaccine for treatment or prevention of a respiratory tract infectionVALNEVA SE·Filed 2020·Granted Dec 10, 2024·0 cites·20 claims
- 2465US2025213667A1Clostridium difficile vaccineVALNEVA AUSTRIA GMBH·Filed 2023·Application pending·0 cites
- 2563US2024026412A1Improved methods of producing a lipidated proteinVALNEVA AUSTRIA GMBH·Filed 2021·Application pending·0 cites
- 2662US2015232517A1MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOVALNEVA AUSTRIA GMBH·Filed 2013·Application pending·0 cites
- 2760US2014212448A1Klebsiella antigensVALNEVA AUSTRIA GMBH·Filed 2013·Application pending·0 cites
- 2857US2015250865A1MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOVALNEVA AUSTRIA GMBH·Filed 2015·Application pending·0 cites
- 2955US2025281589A1Compositions and methods for eliciting an immune response protective against lyme diseasePFIZER·Filed 2023·Application pending·0 cites
- 3054US8637052B2Klebsiella antigensBAKSHI SHARMILA·Filed 2012·Granted Jan 28, 2014·0 cites·80 claims
- 3151US2013116406A1Borrelia antigensINTERCELL AG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Urban Lundberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →